The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 · Journal of Clinical Oncology · 1,843 citations
https://doi.org/10.1200/jco.2008.16.6785
B
Barbara Hero
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
330
Papers
15.2K
Citations
62
h-index
151
i10-index
Barbara Hero is an academic researcher from TH Köln - University of Applied Sciences. The author has contributed to research in topics: Neuroblastoma Research and Treatments & Cancer, Hypoxia, and Metabolism & Cancer therapeutics and mechanisms. The author has an h-index of 62, co-authored 281 publications.
ORCID: 0000-0003-4129-890XPapers by this author
worksGuidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project
2011 · Radiology · 510 citations
https://doi.org/10.1148/radiol.11101352
Neuroblastoma
2021 · Pediatric Blood & Cancer · 144 citations
https://doi.org/10.1002/pbc.28473
Surface‐binding autoantibodies to cerebellar neurons in opsoclonus syndrome
2005 · Annals of Neurology · 104 citations
https://doi.org/10.1002/ana.20539
Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months
2017 · BMC Cancer · 81 citations
https://doi.org/10.1186/s12885-017-3493-0
Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome
2023 · Nature Genetics · 79 citations
https://doi.org/10.1038/s41588-023-01332-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat